United Kingdom OTC (Over-the-Counter) Drug Market Insight
Published: 23 July 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The United Kingdom OTC (Over-the-Counter) Drug Market was valued at USD 7.82 Billion in 2025 and is projected to reach USD 12.94 Billion by 2035, expanding at a CAGR of 5.16% during the forecast period. Market growth is supported by increasing consumer preference for self-medication, rising prevalence of minor ailments, expanding pharmacy retail networks, growing awareness of preventive healthcare, and the continued availability of non-prescription medicines through both physical and online distribution channels.
United Kingdom OTC (Over-the-Counter) Drug Market Forecasts to 2035
- The United Kingdom OTC (Over-the-Counter) Drug Market Size was estimated at USD 7.82 Billion in 2025.
- The market is expected to grow at a CAGR of 5.16% from 2025 to 2035.
- The market is projected to reach approximately USD 12.94 Billion by 2035.
Notable Insights for the United Kingdom OTC (Over-the-Counter) Drug Market
- Segmentation Based on Product Type, Cold & Cough Remedies accounted for the largest market share of approximately 28.7% in 2025, driven by recurring seasonal illnesses, widespread consumer awareness, and strong demand through retail pharmacies and supermarkets.
- Segmentation Based on Distribution Channel, Pharmacies & Drug Stores represented nearly 61.9% of total market revenue in 2025, supported by pharmacist recommendations, broad product availability, and increasing consumer trust in community healthcare services.
- Haleon plc reported approximately USD 14.34 Billion in revenue during fiscal 2025, supported by strong sales of Sensodyne, Panadol, Voltaren, and other leading consumer healthcare and OTC medicine brands worldwide.
- Johnson & Johnson generated USD 88.82 Billion in revenue during fiscal 2025, reflecting continued demand across consumer healthcare and pharmaceutical portfolios, with well-established OTC brands maintaining strong retail presence in international markets.
Download the eBook (ToC)
Research Methodologies Used to Analyze the United Kingdom OTC (Over-the-Counter) Drug Market
This study combines primary and secondary research methodologies to evaluate the United Kingdom OTC (Over-the-Counter) Drug Market. Primary research includes interviews with OTC medicine manufacturers, pharmacy chains, healthcare professionals, wholesalers, distributors, regulatory experts, and senior executives. Secondary research incorporates company annual reports, NHS publications, MHRA reports, UK government healthcare statistics, trade associations, and pharmaceutical industry databases. Market estimates are derived using top-down and bottom-up approaches, while data triangulation ensures accurate market sizing, competitive benchmarking, and long-term forecasting reliability.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom OTC (Over-the-Counter) Drug Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom OTC (Over-the-Counter) Drug Market
- Haleon plc
- Johnson & Johnson
- Bayer AG
- Perrigo Company plc
- Reckitt Benckiser Group plc
- Sanofi S.A.
- Kenvue Inc.
- Procter & Gamble Co.
- Viatris Inc.
- STADA Arzneimittel AG.
Recent Developments:
- In September 2025, Haleon plc launched an expanded Panadol Advance range in the United Kingdom with improved packaging and enhanced consumer guidance to strengthen its OTC pain relief portfolio across retail pharmacy channels.
- In June 2025, Sanofi and Boots UK announced a strategic collaboration to improve consumer access to selected OTC allergy and digestive health products through integrated in-store health advisory and digital pharmacy services.
Market Segmentation
United Kingdom OTC (Over-the-Counter) Drug Market, By Product Type
- Cold & Cough Remedies
- Analgesics & Pain Relief
- Vitamins & Dietary Supplements
- Gastrointestinal Products
- Dermatology Products
- Eye Care Products
- Allergy Medicines
- Others
United Kingdom OTC (Over-the-Counter) Drug Market, By Dosage Form
- Tablets
- Capsules
- Liquids
- Creams & Ointments
- Sprays
- Powders
- Others
United Kingdom OTC (Over-the-Counter) Drug Market, By Distribution Channel
- Pharmacies & Drug Stores
- Supermarkets & Hypermarkets
- Online Pharmacies
- Convenience Stores
- Others
United Kingdom OTC (Over-the-Counter) Drug Market, By End User
- Adults
- Pediatrics
- Geriatrics
United Kingdom OTC (Over-the-Counter) Drug Market, By Region
- England
- Scotland
- Wales
- Northern Ireland
Expert Views:
The United Kingdom OTC (Over-the-Counter) Drug Market is expected to experience steady growth through 2035, supported by increasing self-care practices, expanding digital pharmacy platforms, and growing consumer preference for accessible non-prescription healthcare products. Companies investing in trusted brands, product innovation, sustainable packaging, and omnichannel retail strategies are likely to strengthen their competitive position as demand for convenient preventive healthcare solutions continues to rise.
Author: Govind and Krishna By Decisions Advisors and Consulting